Publications by authors named "Robin Frye"

Claim this Profile
P
Phase I trial of a new schedule of romidepsin in patients with advanced cancers.
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, Kambiz Ghafourian, James Reynolds, Robin Frye

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
Ronan J Kelly, Robert W Robey, Clara C Chen, Deborah Draper, Victoria Luchenko, A Robin Frye

Oncologist· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma.
Robin Frye, Mary Myers, Karen C Axelrod, Elizabeth A Ness, Richard L Piekarz

Clin J Oncol Nurs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
Richard L Piekarz, Robin Frye, H Miles Prince, Mark H Kirschbaum, Jasmine Zain

Blood· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.
Cliona Grant, Fahd Rahman, Richard Piekarz, Cody Peer, Robin Frye

Expert Rev Anticancer Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.
Susan E Bates, Zhirong Zhan, Kenneth Steadman, Tomasz Obrzut, Victoria Luchenko, Robin Frye

Br J Haematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
Richard L Piekarz, Robin Frye, Maria Turner, John J Wright, Steven L Allen

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma.
Sukyung Woo, Erin R Gardner, Xiaohong Chen, Sandra B Ockers, Caitlin E Baum, Robin Frye

Clin Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma.
Richard L Piekarz, A Robin Frye, John J Wright, Seth M Steinberg, David J Liewehr

Clin Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
James L Mulshine, Jane C Atkinson, Robert O Greer, Vassiliki A Papadimitrakopoulou, Carter Van Waes, Robin Frye

Clin Cancer Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis